Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Free Subscription

Articles published in Compr Psychiatry

Retrieve available abstracts of 30 articles:
HTML format

Single Articles

    July 2024
  1. SHI X, Sun X, Zhang C, Li Z, et al
    Individual stigma in people with severe mental illness: Associations with public stigma, psychological capital, cognitive appraisal and coping orientations.
    Compr Psychiatry. 2024;132:152474.
    PubMed     Abstract available

    May 2024
  2. DE FILIPPIS R, Aloi M, Liuzza MT, Pugliese V, et al
    Aberrant salience mediates the interplay between emotional abuse and positive symptoms in schizophrenia.
    Compr Psychiatry. 2024;133:152496.
    PubMed     Abstract available

    March 2024
  3. SAELE RH, Ndetei DM, Mutiso VN, Mamah D, et al
    Epidemiology of DSM-5 psychiatric disorders in Kenyan Youth with Low and High Psychosis Risk.
    Compr Psychiatry. 2024;131:152473.
    PubMed     Abstract available

    February 2024
  4. ANDREO-JOVER J, Wootton O, Fernandez-Jimenez E, Munoz-Sanjose A, et al
    Adverse childhood experiences and cognition: A cross-sectional study in Xhosa people living with schizophrenia and matched medical controls.
    Compr Psychiatry. 2024;130:152459.
    PubMed     Abstract available

    January 2024
  5. ANDREA S, Jan K, Antonin S, Lea J, et al
    Time is the enemy: Negative symptoms are related to even slight differences in the duration of untreated psychosis.
    Compr Psychiatry. 2024;130:152450.
    PubMed     Abstract available

    December 2023
    Proverb comprehension in schizophrenia: A comprehensive review and meta-analysis.
    Compr Psychiatry. 2023;129:152444.
    PubMed     Abstract available

    November 2023
  7. WOLPE N, Vituri A, Jones PB, Shahar M, et al
    The longitudinal structure of negative symptoms in treatment resistant schizophrenia.
    Compr Psychiatry. 2023;128:152440.
    PubMed     Abstract available

    September 2023
  8. SAMI M, Liddle P
    Neurobiology of psychosis and schizophrenia 2022: Nottingham meeting.
    Compr Psychiatry. 2023;127:152415.

  9. DIDIER PR, Moore TM, Calkins ME, Prettyman G, et al
    Evaluation of a new intrinsic and extrinsic motivation scale in youth with psychosis spectrum symptoms.
    Compr Psychiatry. 2023;127:152413.
    PubMed     Abstract available

    July 2023
  10. MOHN-HAUGEN CR, Moller P, Mohn C, Laroi F, et al
    Anomalous self-experiences and neurocognitive functioning in adolescents at risk for psychosis: Still no significant associations found between these two vulnerability markers.
    Compr Psychiatry. 2023;125:152400.
    PubMed     Abstract available

    May 2023
  11. ZHENG Y, Li Q, Gong B, Xia Y, et al
    Negative-emotion-induced reduction in speech-in-noise recognition is associated with source-monitoring deficits and psychiatric symptoms in mandarin-speaking patients with schizophrenia.
    Compr Psychiatry. 2023;124:152395.
    PubMed     Abstract available

  12. VASKINN A, Engelstad KN, Zamparini M, de Girolamo G, et al
    The "zipper model of empathy" applied to violence in schizophrenia: A search for social cognitive underpinnings of lack of empathic behavior.
    Compr Psychiatry. 2023;124:152391.
    PubMed     Abstract available

    March 2023
  13. MISIAK B, Frydecka D, Kowalski K, Samochowiec J, et al
    Associations of neurodevelopmental risk factors with psychosis proneness: Findings from a non-clinical sample of young adults.
    Compr Psychiatry. 2023;123:152385.
    PubMed     Abstract available

    January 2023
  14. CAO Y, Ji S, Chen Y, Zhang X, et al
    Association between autoimmune diseases of the nervous system and schizophrenia: A systematic review and meta-analysis of cohort studies.
    Compr Psychiatry. 2023;122:152370.
    PubMed     Abstract available

  15. YAN H, Huang Z, Lu Y, Qiu Y, et al
    Associations between metabolic disorders and sleep disturbance in patients with schizophrenia.
    Compr Psychiatry. 2023;122:152369.
    PubMed     Abstract available

    October 2022
  16. VASS E, Simon V, Csukly G, Fekete Z, et al
    Virtual reality-based theory of mind intervention in schizophrenia: Preliminary efficacy results.
    Compr Psychiatry. 2022;119:152350.
    PubMed     Abstract available

  17. RODRIGUEZ-TESTAL JF, Fuentes-Marquez S, Senin-Calderon C, Fernandez-Leon S, et al
    Validation of the aberrant salience inventory in a general and clinical Spanish population.
    Compr Psychiatry. 2022;118:152343.
    PubMed     Abstract available

    July 2022
  18. BIEDERMANN F, Kurzthaler I, Haibach M, Pardeller S, et al
    Driving fitness in clinically stable outpatients with chronic schizophrenia.
    Compr Psychiatry. 2022;118:152340.
    PubMed     Abstract available

  19. RAJENDRAN P, Van Winssen C, Viswasam K, Tariq N, et al
    The psychometric properties of the Nepean Belief Scale as a tool for assessing delusions in schizophrenia and related psychotic disorders.
    Compr Psychiatry. 2022;117:152337.
    PubMed     Abstract available

    May 2022
  20. WIDING L, Simonsen C, Flaaten CB, Haatveit B, et al
    Premorbid characteristics of patients with DSM-IV psychotic disorders.
    Compr Psychiatry. 2022;115:152310.
    PubMed     Abstract available

    March 2022
  21. NADESALINGAM N, Chapellier V, Lefebvre S, Pavlidou A, et al
    Motor abnormalities are associated with poor social and functional outcomes in schizophrenia.
    Compr Psychiatry. 2022;115:152307.
    PubMed     Abstract available

  22. GE F, Huo Z, Liu Y, Du X, et al
    Association between schizophrenia and prostate cancer risk: Results from a pool of cohort studies and Mendelian randomization analysis.
    Compr Psychiatry. 2022;115:152308.
    PubMed     Abstract available

    February 2022
  23. JAYA ES, Pillny M, Lincoln TM, Riehle M, et al
    Does social defeat cause negative symptoms? A prospective study in a multi-national community sample.
    Compr Psychiatry. 2022;113:152289.
    PubMed     Abstract available

    November 2021
  24. DORFLINGER C, LeHew C, Carey H, Roche-Desilets J, et al
    Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients.
    Compr Psychiatry. 2021;111:152269.

    October 2021
  25. AISSA A, Jouini R, Ouali U, Zgueb Y, et al
    Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
    Compr Psychiatry. 2021;112:152280.
    PubMed     Abstract available

    July 2021
  26. HE XY, Hou CL, Huang ZH, Huang YH, et al
    Individuals at ultra-high risk of psychosis and first-degree relatives of patients with schizophreniaexperience impaired family functionality and social support deficit in comparison to healthy controls.
    Compr Psychiatry. 2021;109:152263.
    PubMed     Abstract available

  27. NAVARRA-VENTURA G, Vicent-Gil M, Serra-Blasco M, Massons C, et al
    Group and sex differences in social cognition in bipolar disorder, schizophrenia/schizoaffective disorder and healthy people.
    Compr Psychiatry. 2021;109:152258.
    PubMed     Abstract available

    June 2021
  28. MEDIAVILLA R, Lopez-Arroyo M, Gomez-Arnau J, Wiesepape C, et al
    Autobiographical memory in schizophrenia: The role of metacognition.
    Compr Psychiatry. 2021;109:152254.
    PubMed     Abstract available

    April 2021
  29. PARK HY, Seo E, Park KM, Koo SJ, et al
    Shame and guilt in youth at ultra-high risk for psychosis.
    Compr Psychiatry. 2021;108:152241.
    PubMed     Abstract available

  30. VEGA D, Acosta FJ, Saavedra P
    Nonadherence after hospital discharge in patients with schizophrenia or schizoaffective disorder: A six-month naturalistic follow-up study.
    Compr Psychiatry. 2021;108:152240.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.